Devin Cunning, MD
Otolaryngology · Lake Havasu City, AZNPI 1629035944
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,472 of the $11,124 with a category attached, or 67.2%. Inspire Medical Systems, Inc. accounts for 69.3% of it on its own, with 16 other manufacturers making up the rest. Among otolaryngology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $56.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$8K
- Aerin Medical Inc.$2K
- Sanofi$447
- Optinose US, Inc.$276
- GSK$204
- Itamar Medical Inc$178
- plus $598 from 11 others
Across 2 payments — averaging $1725.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aerin Medical Inc.$3K
What the payments were for
- Consulting fees$1,50013%
- Travel & lodging$2,15119%
- Food & beverage$7,47267%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 116 | $7,714 |
| Aerin Medical Inc. | 6 | $1,707 |
| Sanofi | 17 | $447 |
| Optinose US, Inc. | 17 | $276 |
| GSK | 12 | $204 |
| Itamar Medical Inc | 5 | $178 |
| Acclarent, Inc | 2 | $149 |
| Regeneron Healthcare Solutions, Inc. | 8 | $138 |
| Novartis | 3 | $65 |
| Covidien LP | 2 | $44 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $42 |
| Lilly USA, LLC | 2 | $37 |
| Integra Lifesciences Corporation | 1 | $35 |
| Davol Inc. | 2 | $32 |
| Philips North America LLC | 1 | $28 |
| Phadia US Inc. | 1 | $14 |
| Forte Bio-pharma LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire Upper Airway Stimulation System$2,280
- Inspire$2,058
- VIVAER STYLUS$1,641
- RHINAER STYLUS$141
- DUPIXENT$124
How this compares
$11,124 in reported general payments places this provider in the 90th percentile of 150 otolaryngology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucalaMepolizumab | 13 | $68,756 |
| Levothyroxine Sodium | 323 | $2,986 |
| SynthroidLevothyroxine Sodium | 23 | $1,107 |
| Fluticasone Propionate | 34 | $647 |
| Ofloxacin | 13 | $565 |
| Cefdinir | 15 | $409 |
| Fluocinolone Acetonide Oil | 11 | $375 |
| Methimazole | 34 | $342 |
| Ipratropium Bromide | 19 | $247 |
| Mupirocin | 12 | $198 |
| Prednisone | 76 | $164 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $121 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $108 |
| Trazodone Hcl | 22 | $104 |
| Dexamethasone | 13 | $86 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKNucala | $204 | $68,75613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 150 otolaryngology providers in Arizona.
Other otolaryngology in Lake Havasu City
- Michael PraterLake Havasu City$2K
- Daniel CharousGoodyear$196K
- Jordan WeinerScottsdale$129K
- Lisa GrunebaumScottsdale$121K
- Peter KaiserPhoenix$114K
- Glenn RothmanMesa$51K
- Farhan TaghizadehPhoenix$46K
- Eugene ChangTucson$44K
- Shawn StevensPhoenix$33K
- Brandon FornwaltGlendale$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.